Literature DB >> 24075597

Health problems are more common, but less severe when measured using newer EQ-5D versions.

Benjamin M Craig1, A Simon Pickard, Erica I Lubetkin.   

Abstract

OBJECTIVES: The EuroQol Group recently released youth (Y) and 5-level (5L) versions of its 3-level EQ-5D instrument (3L) that measures health-related quality of life. In this study, we (1) compare 3L, Y, and 5L responses among US adults and (2) assess construct validity. STUDY DESIGN AND
SETTING: Using a nationally representative sample of US adults (N = 2,619), we collected 3L, Y, and 5L responses in random order and estimated their associations and their relationship with a 0 to 100 numerical visual analog scale.
RESULTS: The prevalence of US adults in the best possible EQ-5D state (i.e., 11111) was lower for the Y (38%) and 5L (35%) than for the 3L (44%), capturing more health problems. However, the prevalence of extreme responses in pain/discomfort and anxiety/depression decreased substantially between the 3L and 5L (from 44% to 17% and from 29% to 13%, respectively).
CONCLUSION: Compared with the 3L, the Y and 5L versions describe population health as having more, yet milder, health problems. Although the 5L may have advantages in patient populations in which extreme problems are more prevalent, population studies or studies that follow patients from childhood may consider using the Y.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EQ-5D; EQ-5D-3L; EQ-5D-5L; EQ-5D-Y; EuroQol; PRO; Patient-reported outcomes

Mesh:

Year:  2013        PMID: 24075597      PMCID: PMC4091801          DOI: 10.1016/j.jclinepi.2013.07.011

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  11 in total

1.  EuroQol--a new facility for the measurement of health-related quality of life.

Authors: 
Journal:  Health Policy       Date:  1990-12       Impact factor: 2.980

2.  Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population.

Authors:  Murtuza Bharmal; Joseph Thomas
Journal:  Value Health       Date:  2006 Jul-Aug       Impact factor: 5.725

3.  A Swedish child-friendly pilot version of the EQ-5D instrument--the development process.

Authors:  Kristina Burström; Ann-Charlotte Egmar; Anna Lugnér; Margareta Eriksson; Magnus Svartengren
Journal:  Eur J Public Health       Date:  2010-04-29       Impact factor: 3.367

4.  [Health related quality of life in type 1 diabetes mellitus].

Authors:  M J Miranda Velasco; E Domínguez Martín; F J Arroyo Díez; P Méndez Pérez; J González de Buitrago Amigo
Journal:  An Pediatr (Barc)       Date:  2012-04-28       Impact factor: 1.500

5.  Development of the EQ-5D-Y: a child-friendly version of the EQ-5D.

Authors:  Nora Wille; Xavier Badia; Gouke Bonsel; Kristina Burström; Gulia Cavrini; Nancy Devlin; Ann-Charlotte Egmar; Wolfgang Greiner; Narcis Gusi; Michael Herdman; Jennifer Jelsma; Paul Kind; Luciana Scalone; Ulrike Ravens-Sieberer
Journal:  Qual Life Res       Date:  2010-04-20       Impact factor: 4.147

6.  Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study.

Authors:  Ulrike Ravens-Sieberer; Nora Wille; Xavier Badia; Gouke Bonsel; Kristina Burström; Gulia Cavrini; Nancy Devlin; Ann-Charlotte Egmar; Narcis Gusi; Michael Herdman; Jennifer Jelsma; Paul Kind; Pedro R Olivares; Luciana Scalone; Wolfgang Greiner
Journal:  Qual Life Res       Date:  2010-04-17       Impact factor: 4.147

7.  A comparison of the EQ-5D and SF-6D across seven patient groups.

Authors:  John Brazier; Jennifer Roberts; Aki Tsuchiya; Jan Busschbach
Journal:  Health Econ       Date:  2004-09       Impact factor: 3.046

8.  Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.

Authors:  M F Janssen; A Simon Pickard; Dominik Golicki; Claire Gudex; Maciej Niewada; Luciana Scalone; Paul Swinburn; Jan Busschbach
Journal:  Qual Life Res       Date:  2012-11-25       Impact factor: 4.147

9.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Authors:  M Herdman; C Gudex; A Lloyd; Mf Janssen; P Kind; D Parkin; G Bonsel; X Badia
Journal:  Qual Life Res       Date:  2011-04-09       Impact factor: 4.147

10.  Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany.

Authors:  Daniela Eidt-Koch; Thomas Mittendorf; Wolfgang Greiner
Journal:  BMC Pediatr       Date:  2009-08-28       Impact factor: 2.125

View more
  27 in total

1.  The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.

Authors:  Chen-Wei Pan; Hong-Peng Sun; Xingzhi Wang; Qinghua Ma; Yong Xu; Nan Luo; Pei Wang
Journal:  Qual Life Res       Date:  2014-12-25       Impact factor: 4.147

2.  Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece.

Authors:  John N Yfantopoulos; Athanasios E Chantzaras
Journal:  Eur J Health Econ       Date:  2016-06-04

3.  Validity of the EQ-5D-5L and reference norms for the Spanish population.

Authors:  Gimena Hernandez; Olatz Garin; Yolanda Pardo; Gemma Vilagut; Àngels Pont; Mónica Suárez; Montse Neira; Luís Rajmil; Inigo Gorostiza; Yolanda Ramallo-Fariña; Juan Cabases; Jordi Alonso; Montse Ferrer
Journal:  Qual Life Res       Date:  2018-05-16       Impact factor: 4.147

4.  Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population.

Authors:  Asrul Akmal Shafie; Annushiah Vasan Thakumar; Ching Jou Lim; Nan Luo
Journal:  Qual Life Res       Date:  2018-10-13       Impact factor: 4.147

5.  Comparing and transforming PROMIS utility values to the EQ-5D.

Authors:  John D Hartman; Benjamin M Craig
Journal:  Qual Life Res       Date:  2017-12-20       Impact factor: 4.147

6.  The Value Adults Place on Child Health and Functional Status.

Authors:  Benjamin M Craig; Derek S Brown; Bryce B Reeve
Journal:  Value Health       Date:  2015-04-15       Impact factor: 5.725

7.  Do health preferences contradict ordering of EQ-5D labels?

Authors:  Benjamin M Craig; A Simon Pickard; Kim Rand-Hendriksen
Journal:  Qual Life Res       Date:  2014-12-18       Impact factor: 4.147

8.  Effects of treatment, choice, and preference on health-related quality-of-life outcomes in patients with posttraumatic stress disorder (PTSD).

Authors:  Quang A Le; Jason N Doctor; Lori A Zoellner; Norah C Feeny
Journal:  Qual Life Res       Date:  2018-03-14       Impact factor: 4.147

9.  The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty.

Authors:  Meridith E Greene; Kevin A Rader; Göran Garellick; Henrik Malchau; Andrew A Freiberg; Ola Rolfson
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

10.  Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.

Authors:  Juntana Pattanaphesaj; Montarat Thavorncharoensap
Journal:  Health Qual Life Outcomes       Date:  2015-02-06       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.